172 related articles for article (PubMed ID: 12197233)
1. Therapy of melanoma with allogeneic melanoma lysates alone or with interferon-alfa.
Mitchell MS; Darrah D; Stevenson L
Cancer Invest; 2002; 20(5-6):759-68. PubMed ID: 12197233
[No Abstract] [Full Text] [Related]
2. Randomized trial of an allogeneic melanoma lysate vaccine with low-dose interferon Alfa-2b compared with high-dose interferon Alfa-2b for Resected stage III cutaneous melanoma.
Mitchell MS; Abrams J; Thompson JA; Kashani-Sabet M; DeConti RC; Hwu WJ; Atkins MB; Whitman E; Ernstoff MS; Haluska FG; Jakowatz JG; Das Gupta TK; Richards JM; Samlowski WE; Costanzi JJ; Aronson FR; Deisseroth AB; Dudek AZ; Jones VE
J Clin Oncol; 2007 May; 25(15):2078-85. PubMed ID: 17513813
[TBL] [Abstract][Full Text] [Related]
3. Does adjuvant vaccine therapy really have activity in malignant melanoma?
Wheatley K; Ives NJ; Lorigan P
J Clin Oncol; 2007 Oct; 25(29):4693; author reply 4693-5. PubMed ID: 17925569
[No Abstract] [Full Text] [Related]
4. Adjuvant application of interferons.
el Kassas H; Kirkwood JM
Semin Oncol; 1996 Dec; 23(6):737-43. PubMed ID: 8970596
[No Abstract] [Full Text] [Related]
5. Melanoma.
Benson C; Gore ME
Cancer Chemother Biol Response Modif; 2001; 19():629-38. PubMed ID: 11686036
[No Abstract] [Full Text] [Related]
6. Perspective on allogeneic melanoma lysates in active specific immunotherapy.
Mitchell MS
Semin Oncol; 1998 Dec; 25(6):623-35. PubMed ID: 9865677
[TBL] [Abstract][Full Text] [Related]
7. Adjuvant therapy for high-risk primary and resected metastatic melanoma.
Hersey P
Intern Med J; 2003; 33(1-2):33-43. PubMed ID: 12534876
[TBL] [Abstract][Full Text] [Related]
8. Melacine: an allogeneic melanoma tumor cell lysate vaccine.
Sosman JA; Sondak VK
Expert Rev Vaccines; 2003 Jun; 2(3):353-68. PubMed ID: 12903801
[TBL] [Abstract][Full Text] [Related]
9. Melanoma adjuvant therapy.
Tarhini AA; Thalanayar PM
Hematol Oncol Clin North Am; 2014 Jun; 28(3):471-89. PubMed ID: 24880942
[TBL] [Abstract][Full Text] [Related]
10. The EORTC melanoma group translational research program on prognostic factors and ultrastaging in association with the adjuvant therapy trials in stage II and stage III melanoma. European Organization for Research and Treatment of Cancer.
Eggermont AM; Keilholz U; Testori A; Cook M; Lienard D; Ruiter DJ
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):38S-40S. PubMed ID: 11599896
[TBL] [Abstract][Full Text] [Related]
11. The Sunbelt Melanoma Trial.
McMasters KM
Ann Surg Oncol; 2001 Oct; 8(9 Suppl):41S-43S. PubMed ID: 11599897
[TBL] [Abstract][Full Text] [Related]
12. Intermediate- and high-risk melanoma.
Agarwala SS
Curr Treat Options Oncol; 2002 Jun; 3(3):205-17. PubMed ID: 12057066
[TBL] [Abstract][Full Text] [Related]
13. Adjuvant IFN alpha2 therapy of melanoma.
Kirkwood JM
Lancet; 1998 Jun; 351(9120):1901-3. PubMed ID: 9654253
[No Abstract] [Full Text] [Related]
14. Adjuvant interferon in the treatment of melanoma.
Middleton MR
Br J Cancer; 1999 Aug; 80(11):1679-80. PubMed ID: 10468281
[No Abstract] [Full Text] [Related]
15. Adjuvant therapy of stage IIIb melanoma with interferon alfa-2b: clinical and immunological relevance.
Doveil GC; Fierro MT; Novelli M; Appino A; Bertero M; Quaglino P; Bernengo MG
Dermatology; 1995; 191(3):234-9. PubMed ID: 8534942
[TBL] [Abstract][Full Text] [Related]
16. Melanoma--part 2: management.
Thirlwell C; Nathan P
BMJ; 2008 Dec; 337():a2488. PubMed ID: 19047194
[No Abstract] [Full Text] [Related]
17. [High-dose interferon-alpha and adjuvant treatment of melanoma with poor prognosis: requiem for a drug marketing license?].
Saiag P
Ann Dermatol Venereol; 1999 Mar; 126(3):211-3. PubMed ID: 10394432
[No Abstract] [Full Text] [Related]
18. Adjuvant use of interferon alpha 2b is not justified in patients with stage IIb/III melanoma.
Bajetta E
Nat Clin Pract Oncol; 2008 Jan; 5(1):4-5. PubMed ID: 18043604
[No Abstract] [Full Text] [Related]
19. Melanoma: adjuvant therapy and other treatment options.
Terando A; Sabel MS; Sondak VK
Curr Treat Options Oncol; 2003 Jun; 4(3):187-99. PubMed ID: 12718796
[TBL] [Abstract][Full Text] [Related]
20. Angiomatoid metastatic melanoma.
Zelger BG; Zelger B
Dermatol Surg; 2004 Feb; 30(2 Pt 2):336-40. PubMed ID: 14871230
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
